LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.

Join Marla Littlejohn and Dr. Gigi for a compelling conversation on dermatology, enriched by Marla's personal experience with psoriasis.

Fentanyl is a wonder drug. Not only is it useful for managing severe pain (e.g., for cancer patients and burn victims) but it ...

'A lot of cases of bowel cancer are diagnosed quite late because there may have not been any signs, but one of the earliest ...

Full body deodorants are all the rage, and Olympic rowers, West End dancers, and I know the best one is from AKT London. You ...

There is higher risk for cardiovascular complications during delivery in pregnant patients with psoriasis compared with patients without psoriasis.

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

Marla Black Morgan, MD, with Phoebe Neurology Associates, presented findings on a study into the diagnostic journey of patients with neuromuscular conditions who have rare diseases at the 2025 ...